154 related articles for article (PubMed ID: 11511170)
1. Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.
Tettey JN; Maggs JL; Rapeport WG; Pirmohamed M; Park BK
Chem Res Toxicol; 2001 Aug; 14(8):965-74. PubMed ID: 11511170
[TBL] [Abstract][Full Text] [Related]
2. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.
Kassahun K; Pearson PG; Tang W; McIntosh I; Leung K; Elmore C; Dean D; Wang R; Doss G; Baillie TA
Chem Res Toxicol; 2001 Jan; 14(1):62-70. PubMed ID: 11170509
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction.
He K; Woolf TF; Kindt EK; Fielder AE; Talaat RE
Biochem Pharmacol; 2001 Jul; 62(2):191-8. PubMed ID: 11389877
[TBL] [Abstract][Full Text] [Related]
4. Identification of glutathione conjugates of troglitazone in human hepatocytes.
Prabhu S; Fackett A; Lloyd S; McClellan HA; Terrell CM; Silber PM; Li AP
Chem Biol Interact; 2002 Nov; 142(1-2):83-97. PubMed ID: 12399157
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
He K; Talaat RE; Pool WF; Reily MD; Reed JE; Bridges AJ; Woolf TF
Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556
[TBL] [Abstract][Full Text] [Related]
6. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.
Sahi J; Hamilton G; Sinz M; Barros S; Huang SM; Lesko LJ; LeCluyse EL
Xenobiotica; 2000 Mar; 30(3):273-84. PubMed ID: 10752642
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation.
Lee JK; Marion TL; Abe K; Lim C; Pollock GM; Brouwer KL
J Pharmacol Exp Ther; 2010 Jan; 332(1):26-34. PubMed ID: 19801447
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.
Yamazaki H; Shibata A; Suzuki M; Nakajima M; Shimada N; Guengerich FP; Yokoi T
Drug Metab Dispos; 1999 Nov; 27(11):1260-6. PubMed ID: 10534310
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of troglitazone in hepatocytes isolated from experimentally induced diabetic rats.
Meechan AJ; Henderson C; Bates CD; Grant MH; Tettey JN
J Pharm Pharmacol; 2006 Oct; 58(10):1359-65. PubMed ID: 17034659
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone thiol adduct formation in human liver microsomes: enzyme kinetics and reaction phenotyping.
Gan J; Qu Q; He B; Shyu WC; Rodrigues AD; He K
Drug Metab Lett; 2008 Aug; 2(3):184-9. PubMed ID: 19356091
[TBL] [Abstract][Full Text] [Related]
11. Biological reactive intermediates in drug discovery and development: a perspective from the pharmaceutical industry.
Baillie TA; Kassahun K
Adv Exp Med Biol; 2001; 500():45-51. PubMed ID: 11764978
[No Abstract] [Full Text] [Related]
12. Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.
Masubuchi Y
Drug Metab Pharmacokinet; 2006 Oct; 21(5):347-56. PubMed ID: 17072088
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats.
Li J; Kaneko T; Wang Y; Qin LQ; Wang PY; Sato A
Toxicology; 2002 Jul; 176(1-2):91-100. PubMed ID: 12062933
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity.
Saha S; New LS; Ho HK; Chui WK; Chan EC
Toxicol Lett; 2010 Feb; 192(2):141-9. PubMed ID: 19854250
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of an oxygen from water into troglitazone quinone by cytochrome P450 and myeloperoxidase.
He K; Talaat RE; Woolf TF
Drug Metab Dispos; 2004 Apr; 32(4):442-6. PubMed ID: 15039298
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
[TBL] [Abstract][Full Text] [Related]
17. Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxicity to HepG2 cells.
Yamamoto Y; Yamazaki H; Ikeda T; Watanabe T; Iwabuchi H; Nakajima M; Yokoi T
Drug Metab Dispos; 2002 Feb; 30(2):155-60. PubMed ID: 11792684
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes.
Ramachandran V; Kostrubsky VE; Komoroski BJ; Zhang S; Dorko K; Esplen JE; Strom SC; Venkataramanan R
Drug Metab Dispos; 1999 Oct; 27(10):1194-9. PubMed ID: 10497147
[TBL] [Abstract][Full Text] [Related]
19. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.
Kostrubsky VE; Vore M; Kindt E; Burliegh J; Rogers K; Peter G; Altrogge D; Sinz MW
Drug Metab Dispos; 2001 Dec; 29(12):1561-6. PubMed ID: 11717175
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion.
Yang K; Brouwer KL
Drug Metab Dispos; 2014 Jul; 42(7):1219-26. PubMed ID: 24799397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
